{"id":"https://openalex.org/W1900544040","doi":null,"title":"Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.","display_name":"Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W1900544040","mag":"1900544040","pmid":"https://pubmed.ncbi.nlm.nih.gov/20054764"},"language":"en","primary_location":{"id":"pmid:20054764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20054764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kardiologia polska","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091537793","display_name":"Agnieszka Pelc-Nowicka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnieszka Pelc-Nowicka","raw_affiliation_strings":["Department of Cardiology, J. Dietl Hospital, Krak\u00f3w, Poland. anieszka@tlen.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, J. Dietl Hospital, Krak\u00f3w, Poland. anieszka@tlen.pl","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086627785","display_name":"Leszek Bryniarski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leszek Bryniarski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103402106","display_name":"Ewa Mirek-Bryniarska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ewa Mirek-Bryniarska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086866882","display_name":"Micha\u0142 Zabojszcz","orcid":"https://orcid.org/0000-0002-5913-3815","observed_orcids":["https://orcid.org/0000-0002-5913-3815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Micha\u0142 Zabojszcz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2116,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.60820297,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"67","issue":"12","first_page":"1335","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dual-antiplatelet-therapy","display_name":"dual antiplatelet therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.8930000066757202},{"id":"https://openalex.org/keywords/long-term-anticoagulation","display_name":"long-term anticoagulation","score":0.878000020980835},{"id":"https://openalex.org/keywords/paroxysmal-atrial-fibrillation","display_name":"paroxysmal atrial fibrillation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.7429999709129333},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.8119999766349792},{"id":"https://openalex.org/keywords/percutaneous-coronary-intervention","display_name":"percutaneous coronary intervention","score":0.8939999938011169},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.8889999985694885},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9859212040901184},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.7643937468528748},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.726298987865448},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.5915766954421997},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.5700578689575195},{"id":"https://openalex.org/C45393284","wikidata":"https://www.wikidata.org/wiki/Q191012","display_name":"Conventional PCI","level":3,"score":0.5249060392379761},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.4981801509857178},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4771796464920044},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.4731784164905548},{"id":"https://openalex.org/C2777785093","wikidata":"https://www.wikidata.org/wiki/Q2032041","display_name":"Unstable angina","level":3,"score":0.4506988823413849},{"id":"https://openalex.org/C2777265216","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Antiplatelet drug","level":4,"score":0.418312132358551},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.410366028547287},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.4102792739868164},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.2959936857223511}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011044","descriptor_name":"Poland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20054764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20054764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kardiologia polska","raw_type":"Journal Article"},{"id":"mag:1900544040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20054764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W19748391","https://openalex.org/W1475865131","https://openalex.org/W1994703729","https://openalex.org/W2011007155","https://openalex.org/W2023134244","https://openalex.org/W2045713748","https://openalex.org/W2054436867","https://openalex.org/W2069049455","https://openalex.org/W2094667843","https://openalex.org/W2101398046","https://openalex.org/W2104286300","https://openalex.org/W2117254307","https://openalex.org/W2122473579","https://openalex.org/W2129125190","https://openalex.org/W2131370832","https://openalex.org/W2134124835","https://openalex.org/W2145632027","https://openalex.org/W2154014063","https://openalex.org/W2162245427","https://openalex.org/W2165180818","https://openalex.org/W2411971210"],"related_works":["https://openalex.org/W4407076899","https://openalex.org/W1960214446","https://openalex.org/W2808220700","https://openalex.org/W2004413589","https://openalex.org/W2894530573","https://openalex.org/W7099826169","https://openalex.org/W2221426131","https://openalex.org/W3160218433","https://openalex.org/W3011980847","https://openalex.org/W2480588396"],"abstract_inverted_index":{"BACKGROUND:":[0],"Dual":[1],"antiplatelet":[2,37,53,213],"therapy":[3,41,75,137,205,269,288],"for":[4,10,19,32,83,91,129,153,174,212,226,277,284,320,327],"12":[5],"months":[6],"is":[7,60,280,302],"currently":[8],"recommended":[9,114],"all":[11],"patients":[12,77,102,145,161,190,271,321],"with":[13,24,64,78,104,133,147,162,242,259,273,323],"acute":[14],"coronary":[15,26],"syndrome":[16],"(ACS),":[17],"both":[18],"those":[20],"treated":[21,167],"pharmacologically":[22,168],"or":[23,131,218],"percutaneous":[25],"interventions":[27],"(PCI).":[28],"Recently,":[29],"the":[30,55,70,89,200,316],"need":[31],"simultaneous":[33],"administration":[34],"of":[35,57,73,113,143,160,189,202,208,231,252,261,267,305],"dual":[36],"and":[38,86,124,210,240,275,308,325],"oral":[39,134],"anticoagulant":[40,135],"(triple":[42,204],"therapy)":[43],"has":[44],"become":[45],"more":[46],"common.":[47],"However,":[48],"in":[49,76,270],"addition":[50],"to":[51,87,109,249],"intensifying":[52],"treatment,":[54],"risk":[56,224],"haemorrhagic":[58,299],"complications":[59],"also":[61,139],"significantly":[62,257],"increased":[63],"triple":[65,74,192,262,268,287],"therapy.":[66,96,193,263,330],"AIM:":[67],"To":[68],"assess":[69,250],"in-hospital":[71],"use":[72,266],"ACS,":[79,148],"who":[80,106,165],"have":[81],"indications":[82,152,276,326],"long-term":[84,154,278,328],"anticoagulation,":[85],"define":[88,315],"reasons":[90,283],"not":[92,285,290],"administering":[93],"such":[94],"a":[95,303],"METHODS:":[97],"The":[98,127,156,170,265,282],"analysis":[99],"included":[100],"298":[101,144],"diagnosed":[103,146],"ACS":[105,123,274,324],"were":[107,166,256],"admitted":[108],"our":[110],"department.":[111],"Analysis":[112],"treatment":[115,203,214,241],"was":[116,138,177,195],"conducted":[117],"upon":[118],"discharge":[119,184],"from":[120,185],"hospital":[121],"after":[122],"during":[125],"hospitalisation.":[126],"reason":[128],"discontinuation":[130],"non-compliance":[132],"(OAC)":[136],"assessed.":[140],"RESULTS:":[141],"Out":[142],"53":[149],"(17.8%)":[150],"had":[151],"anticoagulation.":[155],"largest":[157],"group":[158],"consisted":[159],"unstable":[163],"angina":[164],"(51.7%).":[169],"most":[171],"common":[172],"indication":[173,211],"chronic":[175],"anticoagulation":[176,219,279,329],"paroxysmal":[178],"atrial":[179],"fibrillation":[180],"(AF)":[181],"(62%).":[182],"At":[183],"hospital,":[186],"only":[187,228],"15.1%":[188],"received":[191],"There":[194,301],"no":[196],"significant":[197],"association":[198],"between":[199],"mode":[201],"vs.":[206],"lack":[207,304],"it)":[209],"(p":[215,220,244],"=":[216,221,234,245],"0.18)":[217],"0.27).":[222],"Among":[223],"factors":[225],"bleeding,":[227],"prior":[229],"episode":[230],"bleeding":[232],"[p":[233],"0.0002;":[235],"odds":[236],"ratio":[237],"(OR)":[238],"4.17]":[239],"PCI":[243],"0.02;":[246],"OR":[247],"impossible":[248],"because":[251],"too":[253],"small":[254],"group)":[255],"associated":[258],"withdrawal":[260],"CONCLUSIONS:":[264],"presenting":[272,322],"insufficient.":[281],"prescribing":[286],"are":[289],"clear.":[291],"One":[292],"explanation":[293],"could":[294],"be":[295],"excessive":[296],"concerns":[297],"about":[298],"complications.":[300],"equivocal":[306],"guidelines":[307],"large":[309],"randomised":[310],"trials":[311],"which":[312],"would":[313],"clearly":[314],"optimal":[317],"management":[318],"strategy":[319]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}